Bruggemans A, Vansant G, Van De Velde P, Debyser Z
J Virus Erad. 2023; 9(3):100343.
PMID: 37701289
PMC: 10493508.
DOI: 10.1016/j.jve.2023.100343.
Li Z, Winer R, Ba S, Sy M, Lin J, Feng Q
J Infect Dis. 2022; 227(9):1088-1096.
PMID: 36314598
PMC: 10319963.
DOI: 10.1093/infdis/jiac428.
Raugi D, Diallo K, Diallo M, Faye D, Cisse O, Smith R
Trials. 2021; 22(1):931.
PMID: 34922614
PMC: 8683814.
DOI: 10.1186/s13063-021-05902-5.
Srinivasa S, deFilippi C, Fitch K, Iyengar S, Shen G, Burdo T
J Endocr Soc. 2021; 6(1):bvab175.
PMID: 34909518
PMC: 8664688.
DOI: 10.1210/jendso/bvab175.
Le Hingrat Q, Sereti I, Landay A, Pandrea I, Apetrei C
Front Immunol. 2021; 12:695674.
PMID: 34367156
PMC: 8336601.
DOI: 10.3389/fimmu.2021.695674.
Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa.
Raugi D, Ba S, Cisse O, Diallo K, Tamba I, Ndour C
Clin Infect Dis. 2021; 72(3):369-378.
PMID: 33527119
PMC: 7850514.
DOI: 10.1093/cid/ciaa277.
Validation of the BD FACSPresto system for the measurement of CD4 T-lymphocytes and hemoglobin concentration in HIV-negative and HIV-positive subjects.
Lu X, Sun H, Li H, Xia W, Wu H, Chen D
Sci Rep. 2020; 10(1):19605.
PMID: 33177659
PMC: 7658244.
DOI: 10.1038/s41598-020-76549-6.
HIV-2 Drug Resistance Genotyping from Dried Blood Spots.
Raugi D, Nixon R, Leong S, Faye K, Diatta J, Sall F
J Clin Microbiol. 2020; 59(1).
PMID: 33055182
PMC: 7771475.
DOI: 10.1128/JCM.02303-20.
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F
J Virol. 2020; 94(7).
PMID: 31915276
PMC: 7081896.
DOI: 10.1128/JVI.01504-19.
HIV-2 as a model to identify a functional HIV cure.
Esbjornsson J, Jansson M, Jespersen S, Mansson F, Honge B, Lindman J
AIDS Res Ther. 2019; 16(1):24.
PMID: 31484562
PMC: 6727498.
DOI: 10.1186/s12981-019-0239-x.
Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants.
Smith R, Raugi D, Wu V, Zavala C, Song J, Diallo K
Antimicrob Agents Chemother. 2019; 63(5).
PMID: 30803972
PMC: 6496081.
DOI: 10.1128/AAC.00014-19.
Low-Bias RNA Sequencing of the HIV-2 Genome from Blood Plasma.
James K, I de Silva T, Brown K, Whittle H, Taylor S, McVean G
J Virol. 2018; 93(1).
PMID: 30333167
PMC: 6288329.
DOI: 10.1128/JVI.00677-18.
Antiviral Activity of Cabotegravir against HIV-2.
Smith R, Wu V, Zavala C, Raugi D, Ba S, Seydi M
Antimicrob Agents Chemother. 2018; 62(10).
PMID: 30012774
PMC: 6153831.
DOI: 10.1128/AAC.01299-18.
A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal,....
Ba S, Raugi D, Smith R, Sall F, Faye K, Hawes S
Clin Infect Dis. 2018; 67(10):1588-1594.
PMID: 29672676
PMC: 6927863.
DOI: 10.1093/cid/ciy324.
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children.
Hassan J, Wangai L, Borus P, Khayeka-Wandabwa C, Karani L, Kithinji M
BMC Res Notes. 2017; 10(1):555.
PMID: 29100529
PMC: 5670520.
DOI: 10.1186/s13104-017-2843-y.
Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.
Chang M, Steinmetzer K, Raugi D, Smith R, Ba S, Sall F
J Clin Virol. 2017; 97:22-25.
PMID: 29096389
PMC: 5700839.
DOI: 10.1016/j.jcv.2017.10.013.
Effectiveness of an Integrated Approach to HIV and Hypertension Care in Rural South Africa: Controlled Interrupted Time-Series Analysis.
Ameh S, Klipstein-Grobusch K, Musenge E, Kahn K, Tollman S, Gomez-Olive F
J Acquir Immune Defic Syndr. 2017; 75(4):472-479.
PMID: 28640065
PMC: 5483981.
DOI: 10.1097/QAI.0000000000001437.
Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm.
Chang M, Wong A, Raugi D, Smith R, Seilie A, Ortega J
J Clin Virol. 2016; 86:56-61.
PMID: 27951466
PMC: 5218592.
DOI: 10.1016/j.jcv.2016.11.011.
CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study.
Asfaw A, Ali D, Eticha T, Alemayehu A, Alemayehu M, Kindeya F
PLoS One. 2015; 10(3):e0122583.
PMID: 25816222
PMC: 4376855.
DOI: 10.1371/journal.pone.0122583.
Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.
Vetter B, Orlowski V, Fransen K, Niederhauser C, Aubert V, Brandenberger M
PLoS One. 2014; 9(10):e111552.
PMID: 25343245
PMC: 4208835.
DOI: 10.1371/journal.pone.0111552.